oral semaglutide fda approval Approves Semaglutide: First GLP-1 Weight Loss Pill Oral Semaglutide Gets FDA Approval

Diabet Metab Syndr Obes Target Ther

The analyst projects that orforglipron could generate peak annual revenue of approximately $44 billion, surpassing previous estimates and the consensus of $26 billion

Given the challenges many patients experience in achieving their target blood sugar goals, todays approval of Mounjaro is an important advance in the treatment of type 2 diabetes, he said

Our results suggest that these genes affect the herbivore-induced metabolome of maize plants and the performance of the caterpillars, increasing knowledge on the biosynthesis and signaling pathways of JA, which will not only be important for developing insect-resistant lines of maize, but will elucidate the ancient history of the split between monocots and dicots